Standard Life Aberdeen has seen its share price sky rocket this year, even as negative headlines around the business continue to highlight risks to earnings.
According to a recent poll by Procensus, an opinion-sharing platform for institutional shareholders, SLA was second after Hargreaves Lansdown in a list of stocks which respondents deemed to have the most negative prospects over the coming months. As a result, the SLA stock has fallen three places in its PRO-EU-FIN index over the last three months to sit in 46th place out of 50. In this index, the company ranks worst on growth prospects and competitive advantages/franchise strength, while it only scores above the lowest quintile on one indicator - corporate governance. SLA AGM sees 42...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
